Skip Navigation



eCAM Advance Access published online on April 19, 2006
eCAM, doi:10.1093/ecam/nel020
This Article
Right arrow Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
3/2/209    most recent
nel020v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Vojdani, A.
Right arrow Articles by Erde, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vojdani, A.
Right arrow Articles by Erde, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2006). Published by Oxford University Press. All rights reserved.
Received March 15, 2006
Accepted March 16, 2006

Review

Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: Modulating Allergic and Infectious Disease Pathology (II)

Aristo Vojdani 1 * and Jonathan Erde 1

1 Immunosciences Lab., Inc., 8693 Wilshire Boulevard, Suite 200, Beverly Hills, CA 90211, USA

* To whom correspondence should be addressed.
Aristo Vojdani, E-mail: immunsci{at}ix.netcom.com


  Abstract

Regulatory T (Treg) cells maintain dominant control of immune responses to foreign materials and microbes. Appropriate Treg cell suppression of immune responses is essential for the maintenance of efficacious defensive responses and the limitation of collateral tissue damage due to excess inflammation. Allergy and infection are well studied and frequent afflictions in which Treg cells play an essential role. As such, they provide excellent models to communicate the significance and relevance of Treg cells to complementary and alternative medicine (CAM).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Evid Based Complement Alternat MedHome page
E. R. Secor Jr, W. F. Carson IV, A. Singh, M. Pensa, L. A. Guernsey, C. M. Schramm, and R. S. Thrall
Oral Bromelain Attenuates Inflammation in an Ovalbumin-induced Murine Model of Asthma
Evid. Based Complement. Altern. Med., March 1, 2008; 5(1): 61 - 69.
[Abstract] [Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
N. Yamaguchi, T. Takahashi, M. Sakuma, T. Sugita, K. Uchikawa, S. Sakaihara, T. Kanda, M. Arai, and K. Kawakita
Acupuncture Regulates Leukocyte Subpopulations in Human Peripheral Blood
Evid. Based Complement. Altern. Med., December 1, 2007; 4(4): 447 - 453.
[Abstract] [Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
A. Vojdani and J. Erde
Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: Modulating Tumor Immunity, Autoimmunity and Alloreactive Immunity (III)
Evid. Based Complement. Altern. Med., September 1, 2006; 3(3): 309 - 316.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.